Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Price

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1993
Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonisticP C Wong, P E Aldrich, A T Chiu, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1990
Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agentA T Chiu, D E McCall, W A Price, et al.
Biochemical and Biophysical Research Communications|May 31, 1991
DuP 532: a second generation of nonpeptide angiotensin II receptor antagonistsA T Chiu, D J Carini, J V Duncia, et al.
Journal of Medicinal Chemistry|August 1, 1991
Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensivesD J Carini, J V Duncia, P E Aldrich, et al.
American Journal of Hypertension|April 11, 1991
In vitro pharmacology of DuP 753A T Chiu, D E McCall, W A Price, et al.
Journal of Medicinal Chemistry|May 1, 1990
The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensivesJ V Duncia, A T Chiu, D J Carini, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 31, 2011
Organization of Neonatal Training Program Directors Council responds to the ACGME 2010 Proposed StandardsR M Ryan, L P Brion, S W Aucott, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1993
Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonisticP C Wong, P E Aldrich, A T Chiu, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1990
Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agentA T Chiu, D E McCall, W A Price, et al.
Biochemical and Biophysical Research Communications|May 31, 1991
DuP 532: a second generation of nonpeptide angiotensin II receptor antagonistsA T Chiu, D J Carini, J V Duncia, et al.
Journal of Medicinal Chemistry|August 1, 1991
Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensivesD J Carini, J V Duncia, P E Aldrich, et al.
American Journal of Hypertension|April 11, 1991
In vitro pharmacology of DuP 753A T Chiu, D E McCall, W A Price, et al.
Journal of Medicinal Chemistry|May 1, 1990
The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensivesJ V Duncia, A T Chiu, D J Carini, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 31, 2011
Organization of Neonatal Training Program Directors Council responds to the ACGME 2010 Proposed StandardsR M Ryan, L P Brion, S W Aucott, et al.
Pageof 13